Perspectives on Enquiry & Evidence

Real world evidence (RWE) provides a large and growing source of insights into drug uptake and safety. It is..

A staged investment strategy aligns R&D decisions and financial planning with the interim looks of a clinical trial. If..

For health innovators, trial selection is a key success factor as there are no second chances. But how do you find the..

During the design of a clinical trial, many biotechs want to substantially reduce the risk of a good new therapy being..

“We found an optimal design in hours that might have taken months to find using standard methods,” reflected Fabien..

Earlier this year, Cytel founder Cyrus Mehta observed that clinical trial design is often treated like an art rather..

This new case study shares how Cytel supported a specialist biopharmaceutical company from Phase 2 trial design through..

 Robust go/no-go (GNG) decision-making is essential for effectively managing risk across a clinical portfolio. In early..

  Challenge Our client had the following key questions which they wanted our pharmacometrics group to address for an..